Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

NCT00995345 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: KRP-104
DRUG: Placebo

Sponsor

ActivX Biosciences, Inc.

Collaborators

[object Object]